12 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
National and Kapodistrian University of Athens
Inhibition of secreted phospholipases A2 by 2-oxoamides based ona-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
University of Athens
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
University of Washington
Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.
University of Washington
Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.
Université
In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors.
Cnrs Umr 7175
The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding.
University of Washington
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.
Niddk
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.
Central South University